IL-5 synthesis is upregulated in human nasal polyp tissue - PubMed (original) (raw)
IL-5 synthesis is upregulated in human nasal polyp tissue
C Bachert et al. J Allergy Clin Immunol. 1997 Jun.
Abstract
Background: In most nasal polyps, tissue eosinophilia is a striking finding, the pathologic mechanism of which is not understood.
Objective: This study was performed to investigate a possibly distinct cytokine and chemokine pattern that could explain the characteristic tissue eosinophilia in nasal polyps.
Methods: Polyps from 23 patients and turbinate tissue from 18 control subjects were investigated. The cytokine protein content (IL-1 beta, IL-3, IL-4, IL-5, IL-6, IL-8, IL-10, tumor necrosis factor-alpha, granulocyte-macrophage colony-stimulating factor, IL-1RA, RANTES, GRO-alpha) of tissue homogenates was measured by ELISA. Immunohistochemistry was performed in selected samples to detect IL-5+, major basic protein-positive, and EG2+ cells.
Results: IL-5 was detectable in only one sample of tissue from 18 control subjects but was found in 18 of 23 nasal polyps. Immunohistochemistry revealed an abundant number of IL-5+ cells, of which 69.5% could be identified as eosinophils by morphology. IL-6, IL-8, IL-10, tumor necrosis factor-alpha, GRO-alpha, and RANTES were detected in all specimens, without significant differences between groups (p > or = 0.05), whereas significnatly higher concentrations of IL-1 beta and IL-1RA were found in turbinate mucosa (p < or = 0.05). IL-3 was not detectable: granulocyte-macrophage colony-stimulating factor could only occasionally be found.
Conclusion: This study indicates that IL-5 plays a key role in the pathophysiology of eosinophilic nasal polyps and may be produced by eosinophils.
Similar articles
- [The concentration and expression of IL-5 in human nasal polyp tissue].
Xu R, Li Y, Xie M, Xu G, Zhang G, Wang S. Xu R, et al. Zhonghua Er Bi Yan Hou Ke Za Zhi. 2000 Aug;35(4):251-4. Zhonghua Er Bi Yan Hou Ke Za Zhi. 2000. PMID: 12768697 Chinese. - Concentration, distribution and expression of interleukin-5 in human nasal polyp tissues.
Xu R, Li Y, Xie M, Xu G, Zhang G, Wang S. Xu R, et al. Chin Med J (Engl). 2002 Sep;115(9):1386-9. Chin Med J (Engl). 2002. PMID: 12411119 - Chronic hyperplastic sinusitis: association of tissue eosinophilia with mRNA expression of granulocyte-macrophage colony-stimulating factor and interleukin-3.
Hamilos DL, Leung DY, Wood R, Meyers A, Stephens JK, Barkans J, Meng Q, Cunningham L, Bean DK, Kay AB, et al. Hamilos DL, et al. J Allergy Clin Immunol. 1993 Jul;92(1 Pt 1):39-48. doi: 10.1016/0091-6749(93)90035-e. J Allergy Clin Immunol. 1993. PMID: 8335853 - Interleukin 5, IL6, IL12, IFN-gamma, RANTES and Fractalkine in human nasal polyps, turbinate mucosa and serum.
Danielsen A, Tynning T, Brokstad KA, Olofsson J, Davidsson A. Danielsen A, et al. Eur Arch Otorhinolaryngol. 2006 Mar;263(3):282-9. doi: 10.1007/s00405-005-1031-1. Epub 2006 Feb 3. Eur Arch Otorhinolaryngol. 2006. PMID: 16456693 - Nasal polyposis: eosinophils and interleukin-5.
Kramer MF, Rasp G. Kramer MF, et al. Allergy. 1999 Jul;54(7):669-80. doi: 10.1034/j.1398-9995.1999.00095.x. Allergy. 1999. PMID: 10442522 Review. No abstract available.
Cited by
- A RESPONSE to anti-IL-5 therapy in comorbid patients with chronic rhinosinusitis with nasal polyps and severe asthma: Study protocol.
Bakakos P, Alobid I, Constantinidis J, Hellings P, Pfaar O, Taillé C, Bañas-Conejero D, Kallinikou K, Howarth P, Schleich F. Bakakos P, et al. J Allergy Clin Immunol Glob. 2024 Sep 17;4(1):100343. doi: 10.1016/j.jacig.2024.100343. eCollection 2025 Feb. J Allergy Clin Immunol Glob. 2024. PMID: 39554605 Free PMC article. - Characteristics of mucin hypersecretion in different inflammatory patterns based on endotypes of chronic rhinosinusitis.
Zhai Z, Shao L, Lu Z, Yang Y, Wang J, Liu Z, Wang H, Zheng Y, Lu H, Song X, Zhang Y. Zhai Z, et al. Clin Transl Allergy. 2024 Jan;14(1):e12334. doi: 10.1002/clt2.12334. Clin Transl Allergy. 2024. PMID: 38282195 Free PMC article. Review. - The Association Between Eosinophils and the Disease Process in Destructive Non-invasive Fungal Rhinosinusitis.
Almaghrabi AA, Alnoury KI, Alkhulaifi AK. Almaghrabi AA, et al. Cureus. 2023 Oct 5;15(10):e46558. doi: 10.7759/cureus.46558. eCollection 2023 Oct. Cureus. 2023. PMID: 37808600 Free PMC article. - Type 2 chronic inflammatory diseases: targets, therapies and unmet needs.
Kolkhir P, Akdis CA, Akdis M, Bachert C, Bieber T, Canonica GW, Guttman-Yassky E, Metz M, Mullol J, Palomares O, Renz H, Ständer S, Zuberbier T, Maurer M. Kolkhir P, et al. Nat Rev Drug Discov. 2023 Sep;22(9):743-767. doi: 10.1038/s41573-023-00750-1. Epub 2023 Aug 1. Nat Rev Drug Discov. 2023. PMID: 37528191 Review. - Effect of Dupilumab on Type 2 Biomarkers in Chronic Rhinosinusitis With Nasal Polyps: SINUS-52 Study Results.
Bachert C, Laidlaw TM, Cho SH, Mullol J, Swanson BN, Naimi S, Classe M, Harel S, Jagerschmidt A, Laws E, Ruddy M, Praestgaard A, Amin N, Mannent LP. Bachert C, et al. Ann Otol Rhinol Laryngol. 2023 Dec;132(12):1649-1661. doi: 10.1177/00034894231176334. Epub 2023 Jun 15. Ann Otol Rhinol Laryngol. 2023. PMID: 37322842 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources